(Re)introducing John
Get to know the rich history and future plans of new vice chancellor for Health Sciences, John M. Carethers.
Get to know the rich history and future plans of new vice chancellor for Health Sciences, John M. Carethers.
UC San Diego researchers report that a late-stage, pre-clinical small molecule inhibitor reverses malignant hyper-editing by a protein that promotes silencing of the immune response, metastasis and therapeutic resistance in 20 different cancer types.
With a generous $22 million in gifts from Joan and Irwin Jacobs, UC San Diego Health will bring its Center for Health Innovation into full reality.
Toddlers’ level of attention to "motherese" speech can be used as a biomarker for autism spectrum disorder (ASD). UC San Diego scientists developed a new eye-tracking test to measure it, which can accurately identify toddlers with a subtype of ASD.
A novel drug combination for leukemia, pioneered at UC San Diego Health, provides patients with a better treatment option that results in less side effects and can put patients in remission.
UC San Diego Health's Center for Transplantation is among the nation's best in lung, heart, kidney and liver programs, powered by long experience and deep expertise.
U.S. News & World Report, June 9
Women's Health, June 3
The New York Times, June 2
The San Diego Union-Tribune, May 23
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
You have been successfully subscribed to the UC San Diego Today Newsletter.